HS Icon Heparin, salts, for therapeutic use

300190 (Harmonized System 1992 for 6-digit)

World Trade (2018): $3.97B, Rnk 790 / 4726

Top Exporter (2018): $1.23B, China

Top Importer (2018): $958M, France

Product Complexity (2018): 0.87, Rnk 1007 / 4873

Export Growth (CAGR)(2017 - 2018): 88.2%, Rnk 108 / 4726

Mean Tariff (2018): 1.16%, Rnk 6360 / 6538

Share of World Trade (2018): 0.022%, Rnk 790 / 4726

Overview:  This page contains the latest trade data of Heparin, salts, for therapeutic use. In 2018, Heparin, salts, for therapeutic use were the world's 790th most traded product, with a total trade of $3.97B. Between 2017 and 2018 the exports of Heparin, salts, for therapeutic use grew by 88.2%, from  $2.11B to $3.97B. Trade in Heparin, salts, for therapeutic use represent 0.022% of total world trade.

Exports: In 2018 the top exporters of Heparin, salts, for therapeutic use  were China ($1.23B), Singapore ($623M), United States ($522M), France ($475M), and Germany ($148M).

Imports: In 2018 the top importers of Heparin, salts, for therapeutic use were France ($958M), Singapore ($424M), United States ($379M), Germany ($235M), and Hong Kong ($211M).

Tariffs: In 2018 the average tariff for Heparin, salts, for therapeutic use was 1.16%, been the 6360 lowest tariff using the HS6 product classification.

The countries with the highest import tariffs for Heparin, salts, for therapeutic use are Nepal (9.89%), India (8.18%), Morocco (7.86%), Hungary (6%), and Aruba (6%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ethiopia (0%), Ghana (0%), and Guinea (0%).

Ranking: Heparin, salts, for therapeutic use ranks 1007th in the Product Complexity Index (PCI).

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2018): China, $1.23B

Top Destination (2018): France, $958M

Heparin, salts, for therapeutic use are the world's 790th most traded product.

In 2018, the top exporters of Heparin, salts, for therapeutic use were China ($1.23B), Singapore ($623M), United States ($522M), France ($475M), and Germany ($148M).

In 2018, the top importers of Heparin, salts, for therapeutic use were France ($958M), Singapore ($424M), United States ($379M), Germany ($235M), and Hong Kong ($211M).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2017 -  2018): Singapore, $623M

Top Destination Growth (2017 - 2018): France, $509M

Between 2017 and 2018, the exports of Heparin, salts, for therapeutic use grew the fastest in Singapore ($623M), China ($439M), France ($423M), Sweden ($141M), and United States ($108M).

Between 2017 and 2018, the fastest growing importers of Heparin, salts, for therapeutic use were France ($509M), Singapore ($424M), Hungary ($191M), Hong Kong ($173M), and Germany ($101M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

This chart shows the evolution of the market concentration of exports of Heparin, salts, for therapeutic use.

In 2018,  market concentration measured using Shannon Entropy, was 3.37. This means that most of the exports of Heparin, salts, for therapeutic use are explained by 10 countries.

Explore Visualizations

TOP NET EXPORTER (2018): China, $1.18B

TOP NET IMPORTER (2018): France, $482M

This map shows which countries export or import more of Heparin, salts, for therapeutic use. Each country is colored based on the difference in exports and imports of Heparin, salts, for therapeutic use during 2018.

In 2018, the countries that had a largest trade value in exports than in imports of Heparin, salts, for therapeutic use were China ($1.18B), Singapore ($199M), United States ($144M), Ireland ($110M), and Netherlands ($50.5M).

In 2018, the countries that had a largest trade value in imports than in exports of Heparin, salts, for therapeutic use were France ($482M), Hong Kong ($209M), Hungary ($185M), Belgium-Luxembourg ($104M), and Germany ($87.3M).

Trade Forecasts

#permalink to section

This section shows forecasts for total trade for Heparin, salts, for therapeutic use. The forecast is based in a long short-term memory model or LSTM constructed using yearly trade data.

Explore Forecasts

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Heparin, salts, for therapeutic use was 1.16%.  The countries with the highest tariffs for importing Heparin, salts, for therapeutic use were Nepal (9.89%), India (8.18%), Morocco (7.86%), Hungary (6%), and Aruba (6%).

Explore Tariff Data

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Filter

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.